StoneMill Pharma
StoneMill Pharma
StoneMill Pharma

Tag: Hatch-Waxman Act

blg-img3-1.jpg
Feb 1, 2026
  • Miranda Rathbone
  • 14

How Multiple Generic Drug Competitors Enter After the First Market Entrant

After the first generic enters the market, prices collapse - but not because of competition alone. Authorized generics, PBM deals, manufacturing shortages, and patent delays shape how and when competitors enter - and who wins.

Recent Posts

How Generic Drugs Impact Brand Manufacturers: Industry Economics Explained
Mar 25, 2026
How Generic Drugs Impact Brand Manufacturers: Industry Economics Explained
Medications That Are High-Risk for Seniors: What to Review
Mar 17, 2026
Medications That Are High-Risk for Seniors: What to Review
Statin Interactions That Increase Myopathy Risk: What You Need to Know
Jan 15, 2026
Statin Interactions That Increase Myopathy Risk: What You Need to Know
Inactive Ingredients in Generic Medications: What You Need to Know
Jan 20, 2026
Inactive Ingredients in Generic Medications: What You Need to Know
How to Report a Medication Safety Concern to Your Clinic
Nov 23, 2025
How to Report a Medication Safety Concern to Your Clinic

Categories

  • Health (184)
  • Lifestyle (3)
  • Technology (1)

Archives

  • May 2026 (6)
  • April 2026 (14)
  • March 2026 (13)
  • February 2026 (14)
  • January 2026 (26)
  • December 2025 (26)
  • November 2025 (22)
  • October 2025 (27)
  • September 2025 (14)
  • August 2025 (4)
  • July 2025 (21)
  • June 2025 (6)
StoneMill Pharma
  • About
  • Terms of Service
  • Privacy Policy
  • Data Protection Rights
  • Contact

© 2026. All rights reserved.